Implicaciones clínicas de la lesión renal aguda, su relación con el grupo etario y la mortalidad en adultos críticamente enfermos con infección por SARS-CoV-2 durante el año 2021
| datacite.rights | http://purl.org/coar/access_right/c_f1cf | |
| dc.contributor.advisor | Guido Musso, Carlos | |
| dc.contributor.advisor | Aldana Roa, Mauricio | |
| dc.contributor.advisor | González-Torres, Henry Joseth | |
| dc.contributor.author | Acosta Muñoz, Jorge Luis | |
| dc.date.accessioned | 2025-02-07T16:24:42Z | |
| dc.date.available | 2025-02-07T16:24:42Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | La lesión renal aguda (LRA) es una manifestación grave en pacientes con COVID-19. Su presencia se relaciona con vigilancia en cuidados intensivos, mayores complicaciones y un mal pronóstico. Objetivos: Evaluar las implicaciones clínicas de LRA, su relación con el grupo etario y la mortalidad en adultos críticamente enfermos con infección por SARS-CoV-2. Materiales y métodos: Analítico, correlacional, retrospectivo. Se incluyó pacientes ≥18 años con neumonía por SARS-CoV-2, ingresados a cuidados intensivos en Barranquilla (Colombia) entre enero y diciembre del año 2021. Se dividieron según la presencia de LRA y se caracterizó acorde a la edad. Los datos se evaluaron mediante regresión logística univariado. La mortalidad se determinó a través cocientes de riesgos instantáneos (HR) con intervalos de confianza al 95%. Resultados: Se incluyeron 199 pacientes. La prevalencia de LRA fue 59.8% y fue frecuente entre 45 – 65 años. Los pacientes con LRA presentaron APACHE II elevado, presencia de diabetes mellitus (27.6%), necesidad de VMI (75.4%), aminas vasoactivas y altos niveles de ferritina y lactato deshidrogenasa (LDH). La presencia de LRA no influyo en un riesgo de mortalidad (HR = 1.73: IC 95% [1.12 – 2.68]; p = 0.013). | spa |
| dc.description.abstract | Acute kidney injury (AKI) is a severe manifestation in patients with COVID-19. Its presence is associated with intensive care monitoring, increased complications, and a poor prognosis. Objectives: To assess the clinical implications of AKI, its relationship with age group, and mortality in critically ill adults with SARS-CoV-2 infection. Materials and Methods: Analytical, correlational, retrospective. Patients ≥18 years of age with SARS-CoV-2 pneumonia admitted to intensive care in Barranquilla (Colombia) between January and December 2021 were included. They were divided according to the presence of AKI and characterized according to age. Data were evaluated using univariate logistic regression. Mortality was determined using hazard ratios (HR) with 95% confidence intervals. Results: A total of 199 patients were included. The prevalence of AKI was 59.8% and it was frequent between 45 and 65 years of age. Patients with AKI had elevated APACHE II, presence of diabetes mellitus (27.6%), need for IMV (75.4%), vasoactive amines, and high levels of ferritin and lactate dehydrogenase (LDH). AKI did not influence the mortality risk (HR = 1.73: 95% CI [1.12 – 2.68]; p = 0.013). | eng |
| dc.format.mimetype | ||
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/16237 | |
| dc.language.iso | spa | |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | eng |
| dc.rights.accessrights | info:eu-repo/semantics/embargoedAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | |
| dc.subject | Lesión renal aguda | spa |
| dc.subject | Grupo etario | spa |
| dc.subject | SARS-CoV-2 | spa |
| dc.subject | Críticamente enfermos | spa |
| dc.subject.keywords | Acute kidney injury | eng |
| dc.subject.keywords | Age groups | eng |
| dc.subject.keywords | Critically ill | eng |
| dc.title | Implicaciones clínicas de la lesión renal aguda, su relación con el grupo etario y la mortalidad en adultos críticamente enfermos con infección por SARS-CoV-2 durante el año 2021 | spa |
| dc.type.driver | info:eu-repo/semantics/other | |
| dc.type.spa | Otros | |
| dcterms.references | Martin de Francisco Á, Fernández Fresnedo G. Enfermedad renal en la COVID-19 persistente: un objetivo inmediato para Nefrología. Nefrología [Internet]. 2023 Jan;43(1):1–5. Available from: https://doi.org/10.1016/j.nefro.2022.04.004 | spa |
| dcterms.references | Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med [Internet]. 2020 Mar 26;382(13):1199–207. Available from: https://doi.org/10.1056/NEJMoa2001316 | eng |
| dcterms.references | Salazar-Martínez E, Hernández-Mariano JÁ, Galván-Portillo M, Baltazar-Reyes MC, Parra-Cabrera MS, Tamayo y Orozco JA, et al. Marcadores de funcionamiento renal en pacientes infectados por SARS-CoV-2. Revisión rápida de la literatura. Salud Publica Mex [Internet]. 2021 Jan 14;63(2, Mar–Abr):253–61. Available from: https://doi.org/10.21149/11918 | spa |
| dcterms.references | Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S, et al. AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol [Internet]. 2021 Jan;32(1):151–60. Available from: https://doi.org/10.1681/ASN.2020050615 | eng |
| dcterms.references | Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology [Internet]. 2020 Aug 5;77(2):198– 209. Available from: https://doi.org/10.1111/his.14134 | eng |
| dcterms.references | Sawhney S, Fraser SD. Epidemiology of AKI: Utilizing Large Databases to Determine the Burden of AKI. Adv Chronic Kidney Dis [Internet]. 2017 Jul;24(4):194–204. Available from: https://dx.doi.org/10.1053/j.ackd.2017.05.001 | eng |
| dcterms.references | Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol [Internet]. 2018 Oct 22;14(10):607–25. Available from: https://dx.doi.org/10.1038/s41581-018-0052-0 | eng |
| dcterms.references | McMahon BA, Koyner JL. Risk Stratification for Acute Kidney Injury: Are Biomarkers Enough? Adv Chronic Kidney Dis [Internet]. 2016 May;23(3):167–78. Available from: https://dx.doi.org/10.1053/j.ackd.2016.03.001 | eng |
| dcterms.references | Algarín-Lara H, Guevara-Romero E, Osorio-Rodríguez E, Patiño-Patiño J, Flórez García V, Tuesca R de J, et al. Factores relacionados con la neumonía bacteriana en pacientes con COVID-19 en una unidad de cuidados intensivos de Barranquilla, Colombia. Acta Colomb Cuid Intensivo [Internet]. 2022 Jun;22:S28–35. Available from: https://doi.org/10.1016/j.acci.2021.07.002 | spa |
| dcterms.references | Organización Panamericana de la Salud. Monthly COVID-19 Epidemiological Update - Region of the Americas - 02 August 2023 [Internet]. Organización Panamericana de la Salud. 2023. p. 1–10. Available from: https://www.paho.org/en/documents/monthly-covid-19-epidemiological-update region-americas-02-august-2023 | eng |
| dcterms.references | Osorio-Rodríguez E, Aldana-Roa M, Patiño-Patiño JJ, Rodado-Villa R, Ariza Miranda L, Aldana-Roa JD, et al. Sobreinfecciones intrahospitalarias y su relación con la mortalidad en pacientes obesos o diabéticos con COVID-19 críticamente enfermos. Acta Colomb Cuid Intensivo [Internet]. 2024 Jan; Available from: https://doi.org/10.1016/j.acci.2023.12.002 | spa |
| dcterms.references | Algarín-Lara H, Osorio-Rodríguez E, Patiño-Patiño J, Mendoza-Morales I, Rodado Villa R. Neumonía por SARS-CoV-2 asociado a coinfección por Pneumocystis jirovecii en paciente inmunocomprometido: a propósito de un caso y revisión de la literatura. Acta Colomb Cuid Intensivo [Internet]. 2022 Jun;22:S106–13. Available from: https://doi.org/10.1016/j.acci.2021.07.001 | eng |
| dcterms.references | Algarín-Lara H, Rudas Moscarella JM, Aldana-Roa J, Patiño-Patiño J, Sajona Nieves E, Aldana-Roa M, et al. Superinfección por Stenotrophomonas maltophilia en pacientes con COVID-19 críticamente enfermos. Análisis de una serie de casos. Acta Colomb Cuid Intensivo [Internet]. 2022 Jun;22:S138–42. Available from: https://doi.org/10.1016/j.acci.2021.08.001 | spa |
| dcterms.references | Algarín Lara H, Rodado Villa R, Aldana Roa MF, Osorio Rodríguez EL, Patiño Patiño JJ. Neumotórax espontáneo primario no asociado a ventilación mecánica invasiva en pacientes con neumonía por COVID-19. Presentación de 2 casos. Acta Colomb Cuid Intensivo [Internet]. 2022 Apr;22(2):149–53. Available from: https://doi.org/10.1016/j.acci.2021.03.002 | spa |
| dcterms.references | Algarin-Lara H, Osorio-Rodríguez E, Patiño-Patiño J, Solano-Ropero J, Rodado Villa R. Hipercapnia refractaria en paciente con síndrome de obesidad hipoventilación maligno y COVID-19. Reporte de caso y propuesta de manejo. Acta Colomb Cuid Intensivo [Internet]. 2022 Jun;22:S117–22. Available from: https://doi.org/10.1016/j.acci.2021.09.005 | spa |
| dcterms.references | Moore PK, Hsu RK, Liu KD. Management of Acute Kidney Injury: Core Curriculum 2018. Am J Kidney Dis [Internet]. 2018 Jul;72(1):136–48. Available from: https://doi.org/10.1053/j.ajkd.2017.11.021 | eng |
| dcterms.references | Cheng Y, Luo R, Wang X, Wang K, Zhang N, Zhang M, et al. The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019. Clin J Am Soc Nephrol [Internet]. 2020 Oct 7;15(10):1394–402. Available from: https://doi.org/10.2215/CJN.04650420 | eng |
| dcterms.references | Vargas JG, Avila N, Hurtado D, Cárdenas-Roldán J, Peña D, Ortiz G. Lesión renal aguda en COVID-19: puesta al día y revisión de la literatura. Acta Colomb Cuid Intensivo [Internet]. 2022 Jan;22(1):24–34. Available from: https://doi.org/10.1016/j.acci.2020.10.004 | spa |
| dcterms.references | Stockmann H, Hardenberg J-HB, Aigner A, Hinze C, Gotthardt I, Stier B, et al. High rates of long-term renal recovery in survivors of coronavirus disease 2019– associated acute kidney injury requiring kidney replacement therapy. Kidney Int [Internet]. 2021 Apr;99(4):1021–2. Available from: https://doi.org/10.1016/j.kint.2021.01.005 | eng |
| dcterms.references | Weber DJ, Rutala WA, Fischer WA, Kanamori H, Sickbert-Bennett EE. Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza vi. Am J Infect Control [Internet]. 2016 May;44(5):e91–100. Available from: https://dx.doi.org/10.1016/j.ajic.2015.11.018 | eng |
| dcterms.references | Chilamakuri R, Agarwal S. COVID-19: Characteristics and Therapeutics. Cells [Internet]. 2021 Jan 21;10(2):206. Available from: https://doi.org/10.3390/cells10020206 | eng |
| dcterms.references | Fabrizi F, Nardelli L, Regalia A, Zanoni F, Castellano G. Are Kidneys Affected by SARS-CoV-2 Infection? An Updated Review on COVID-19-Associated AKI. Pathogens [Internet]. 2024 Apr 16;13(4):325. Available from: https://doi.org/10.3390/pathogens13040325 | eng |
| dcterms.references | Long B, Carius BM, Chavez S, Liang SY, Brady WJ, Koyfman A, et al. Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation. Am J Emerg Med [Internet]. 2022 Apr;54:46–57. Available from: https://doi.org/10.1016/j.ajem.2022.01.028 | eng |
| dcterms.references | Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med [Internet]. 2022 Sep;10(9):863–76. Available from: https://doi.org/10.1016/S2213-2600(22)00126-6 | eng |
| dcterms.references | Ng JH, Hirsch JS, Hazzan A, Wanchoo R, Shah HH, Malieckal DA, et al. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. Am J Kidney Dis [Internet]. 2021 Feb;77(2):204–215.e1. Available from: https://doi.org/10.1053/j.ajkd.2020.09.002 | eng |
| dcterms.references | Gómez-Ochoa SA, Franco OH, Rojas LZ, Raguindin PF, Roa-Díaz ZM, Wyssmann BM, et al. COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol [Internet]. 2021 Jan 4;190(1):161–75. Available from: https://doi.org/10.1093/aje/kwaa191 | eng |
| dcterms.references | Zhang Y, Li H, Zhang J, Cao Y, Zhao X, Yu N, et al. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single‐centre, retrospective, observational study in Wuhan. Diabetes, Obes Metab [Internet]. 2020 Aug 17;22(8):1443–54. Available from: https://doi.org/10.1111/dom.14086 | eng |
| dcterms.references | Rajpal A, Rahimi L, Ismail‐Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes [Internet]. 2020 Dec 2;12(12):895–908. Available from: https://doi.org/10.1111/1753-0407.13085 | eng |
| dcterms.references | Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, et al. Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors. Allergy [Internet]. 2020 Nov 24;75(11):2829–45. Available from: https://doi.org/10.1111/all.14429 | eng |
| dcterms.references | Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID 19. Thromb Res [Internet]. 2020 Jul;191:145–7. Available from: https://doi.org/10.1016/j.thromres.2020.04.013 | eng |
| dcterms.references | Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract [Internet]. 2012 Aug 7;120(4):c179–84. Available from: https://doi.org/10.1159/000339789 | eng |
| dcterms.references | Wang L, Li X, Chen H, Yan S, Li D, Li Y, et al. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Am J Nephrol [Internet]. 2020;51(5):343–8. Available from: https://doi.org/10.1159/000507471 | eng |
| dcterms.references | Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS CoV-2? Am J Physiol Physiol [Internet]. 2020 Jun 1;318(6):F1454–62. Available from: https://doi.org/10.1152/ajprenal.00160.2020 | eng |
| dcterms.references | Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol [Internet]. 2021 Nov 5;17(11):751–64. Available from: https://doi.org/10.1038/s41581-021-00452-0 | eng |
| dcterms.references | Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol [Internet]. 2004 Jun 7;203(2):631–7. Available from: https://doi.org/10.1002/path.1570 | eng |
| dcterms.references | Diao B, Wang C, Wang R, Feng Z, Zhang J, Yang H, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun [Internet]. 2021 May 4;12(1):2506. Available from: https://doi.org/10.1038/s41467- 021-22781-1 | eng |
| dcterms.references | Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int [Internet]. 2020 May;97(5):829–38. Available from: https://doi.org/10.1016/j.kint.2020.03.005 | eng |
| dcterms.references | Rabb H. Kidney diseases in the time of COVID-19: major challenges to patient care. J Clin Invest [Internet]. 2020 May 11;130(6):2749–51. Available from: https://doi.org/10.1172/JCI138871 | eng |
| dcterms.references | Zhang WR, Parikh CR. Biomarkers of Acute and Chronic Kidney Disease. Annu Rev Physiol [Internet]. 2019 Feb 10;81(1):309–33. Available from: https://doi.org/10.1146/annurev-physiol-020518-114605 | eng |
| dcterms.references | Razi O, Teixeira AM, Tartibian B, Zamani N, Knechtle B. Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise. Mol Cell Biochem [Internet]. 2023 Jul 21;478(7):1533– 59. Available from: https://doi.org/10.1007/s11010-022-04610-1 | eng |
| dcterms.references | Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal [Internet]. 2020;10(2):102–8. Available from: https://doi.org/10.1016/j.jpha.2020.03.001 | eng |
| dcterms.references | Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol [Internet]. 2020 Apr 7;92(4):424–32. Available from: https://doi.org/10.1002/jmv.25685 | eng |
| dcterms.references | Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the Eye of the Cytokine Storm. Microbiol Mol Biol Rev [Internet]. 2012 Mar;76(1):16–32. Available from: https://doi.org/10.1128/MMBR.05015-11 | eng |
| dcterms.references | Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, et al. Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol [Internet]. 2021 May 6;31(3). Available from: https://doi.org/10.1002/rmv.2176 | eng |
| dcterms.references | Gupta A, Madhavan M V., Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med [Internet]. 2020 Jul 10;26(7):1017–32. Available from: https://doi.org/10.1038/s41591-020-0968-3 | eng |
| dcterms.references | Caicedo Mesa A, Méndez Fandiño YR, Larrotta Salamanca LX, Díaz Lache LL, Forero Alvarado MJ, Cortés Motta HF, et al. Pandemia de COVID-19 y enfermedad renal ¿qué sabemos actualmente? Rev Colomb Nefrol [Internet]. 2020 Jul 16;7(1):23–4. Available from: https://doi.org/10.22265/acnef.7.Supl.2.438 | spa |
| dcterms.references | Fisher M, Neugarten J, Bellin E, Yunes M, Stahl L, Johns TS, et al. AKI in Hospitalized Patients with and without COVID-19: A Comparison Study. J Am Soc Nephrol [Internet]. 2020 Sep;31(9):2145–57. Available from: https://doi.org/10.1681/ASN.2020040509 | eng |
| dcterms.references | Wang J, Wang Z, Zhu Y, Li H, Yuan X, Wang X, et al. Identify the Risk Factors of COVID-19-Related Acute Kidney Injury: A Single-Center, Retrospective Cohort Study. Front Med [Internet]. 2020 Jul 28;7. Available from: https://doi.org/10.3389/fmed.2020.00436 | eng |
| dcterms.references | Fominskiy E V., Scandroglio AM, Monti G, Calabrò MG, Landoni G, Dell’Acqua A, et al. Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy. Blood Purif [Internet]. 2021;50(1):102–9. Available from: https://doi.org/10.1159/000508657 | eng |
| dcterms.references | He W, Liu X, Hu B, Li D, Chen L, Li Y, et al. Gender and Ethnic Disparities of Acute Kidney Injury in COVID-19 Infected Patients: A Literature Review. Front Cell Infect Microbiol [Internet]. 2022 Jan 13;11. Available from: https://doi.org/10.3389/fcimb.2021.778636 | eng |
| dcterms.references | Zhang J, Pang Q, Zhou T, Meng J, Dong X, Wang Z, et al. Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta analysis. Ren Fail [Internet]. 2023 Dec 31;45(1). Available from: https://doi.org/10.1080/0886022X.2023.2170809 | eng |
| dcterms.references | Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020 Apr 30;382(18):1708–20. Available from: https://doi.org/10.1056/NEJMoa2002032 | eng |
| dcterms.references | Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet]. 2020 Feb;395(10223):507–13. Available from: https://doi.org/10.1016/S0140-6736(20)30211-7 | eng |
| dcterms.references | Wainstein M, MacDonald S, Fryer D, Young K, Balan V, Begum H, et al. Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID 19: A multinational study using the ISARIC–WHO clinical characterisation protocol. Remuzzi G, editor. PLOS Med [Internet]. 2022 Apr 20;19(4):e1003969. Available from: https://doi.org/10.1371/journal.pmed.1003969 | eng |
| dcterms.references | Chávez-Íñiguez JS, Cano-Cervantes JH, Maggiani-Aguilera P, Lavelle-Góngora N, Marcial-Meza J, Camacho-Murillo EP, et al. Mortality and evolution between community and hospital-acquired COVID-AKI. Bikbov B, editor. PLoS One [Internet]. 2021 Nov 4;16(11):e0257619. Available from: https://doi.org/10.1371/journal.pone.0257619 | eng |
| dcterms.references | Contreras-Villamizar K, Barbosa O, Muñoz AC, Suárez JS, González CA, Vargas DC, et al. Risk factors associated with acute kidney injury in a cohort of hospitalized patients with COVID-19. BMC Nephrol [Internet]. 2023 May 22;24(1):140. Available from: https://doi.org/10.1186/s12882-023-03172-8 | eng |
| dcterms.references | Arenas CL, Forero ACP, Ángel DCV, López PMR, Diaz LVG, Aguilar DKN, et al. Risk factors for acute kidney injury in patients hospitalized with COVID-19. Brazilian J Nephrol [Internet]. 2024 Jun;46(2). Available from: https://doi.org/10.1590/2175- 8239-JBN-2023-0056en | eng |
| dcterms.references | OH TE, HUTCHINSON R, SHORT S, BUCKLEY T, LIN E, LEUNG D. Verification of the Acute Physiology and Chronic Health Evaluation scoring system in a Hong Kong intensive care unit. Crit Care Med [Internet]. 1993 May;21(5):698–705. Available from: https://doi.org/10.1097/00003246-199305000-00013 | eng |
| dcterms.references | Andrade Sierra J, Delgado Astorga C, Nava Vargas MG, Rojas Campos E, Arrelano Arteaga KJ, Hernández Morales K, et al. Procalcitonin and High APACHE (Acute Physiological and Chronic Health Evaluation) Level Are Associated with the Course of Acute Kidney Injury in Patients with SARS-CoV-2. Chen T-C, editor. Int J Clin Pract [Internet]. 2022 Oct 7;2022:1–9. Available from: https://doi.org/10.1155/2022/1363994 | eng |
| dcterms.references | Kolhe N V., Fluck RJ, Selby NM, Taal MW. Acute kidney injury associated with COVID-19: A retrospective cohort study. Remuzzi G, editor. PLOS Med [Internet]. 2020 Oct 30;17(10):e1003406. Available from: https://doi.org/10.1371/journal.pmed.1003406 | eng |
| dcterms.references | See YP, Young BE, Ang LW, Ooi XY, Chan CP, Looi WL, et al. Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study. Nephron [Internet]. 2021;145(3):256–64. Available from: https://doi.org/10.1159/000514064 | eng |
| dcterms.references | Cai X, Wu G, Zhang J, Yang L. Risk Factors for Acute Kidney Injury in Adult Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Med [Internet]. 2021 Dec 6;8. Available from: https://doi.org/10.3389/fmed.2021.719472 | eng |
| dcterms.references | Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int [Internet]. 2020 Jul;98(1):209–18. Available from: https://doi.org/10.1016/j.kint.2020.05.006 | eng |
| dcterms.references | Pelayo J, Lo KB, Bhargav R, Gul F, Peterson E, DeJoy III R, et al. Clinical Characteristics and Outcomes of Community- and Hospital-Acquired Acute Kidney Injury with COVID-19 in a US Inner City Hospital System. Cardiorenal Med [Internet]. 2020;10(4):223–31. Available from: https://doi.org/10.1159/000509182 | eng |
| dcterms.references | Lombardi R, Ferreiro A, Ponce D, Claure-Del Granado R, Aroca G, Venegas Y, et al. Latin American registry of renal involvement in COVID-19 disease. The relevance of assessing proteinuria throughout the clinical course. Dass B, editor. PLoS One [Internet]. 2022 Jan 27;17(1):e0261764. Available from: https://doi.org/10.1371/journal.pone.0261764 | eng |
| dcterms.references | Petrucci N, De Feo C. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev [Internet]. 2013 Feb 28; Available from: https://doi.org/10.1002/14651858.CD003844.pub4 | eng |
| dcterms.references | Bullen A, Liu ZZ, Hepokoski M, Li Y, Singh P. Renal Oxygenation and Hemodynamics in Kidney Injury. Nephron [Internet]. 2017;137(4):260–3. Available from: https://doi.org/10.1159/000477830 | eng |
| dcterms.references | Casas-Aparicio GA, León-Rodríguez I, Alvarado-de la Barrera C, González Navarro M, Peralta-Prado AB, Luna-Villalobos Y, et al. Acute kidney injury in patients with severe COVID-19 in Mexico. Burdmann EA, editor. PLoS One [Internet]. 2021 Feb 8;16(2):e0246595. Available from: https://doi.org/10.1371/journal.pone.0246595 | eng |
| dcterms.references | Denic A, Glassock RJ, Rule AD. Structural and Functional Changes With the Aging Kidney. Adv Chronic Kidney Dis [Internet]. 2016 Jan;23(1):19–28. Available from: https://doi.org/10.1053/j.ackd.2015.08.004 | eng |
| dcterms.references | Oliveira JE de, Santos TA dos, Belasco AGS, Barbosa DA, Santos ES, Góes Junior MA de, et al. Acute kidney injury and COVID-19 in young adults in intensive care. Acta Paul Enferm [Internet]. 2023 Oct 25;37. Available from: https://doi.org/10.37689/acta-ape/2024AO0027511 | eng |
| dcterms.references | Lombardi R, Ferreiro A, Claure-Del Granado R, Burdmann EA, Rosa-Diez G, Yu L,et al. EPILAT-IRA Study: A contribution to the understanding of the epidemiology of acute kidney injury in Latin America. Lazzeri C, editor. PLoS One [Internet]. 2019 Nov 14;14(11):e0224655. Available from: https://doi.org/10.1371/journal.pone.0224655 | eng |
| dcterms.references | de Almeida DC, Franco M do CP, dos Santos DRP, Santos MC, Maltoni IS, Mascotte F, et al. Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients. Seguro AC, editor. PLoS One [Internet]. 2021 May 25;16(5):e0251048. Available from: https://doi.org/10.1371/journal.pone.0251048 | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | |
| sb.programa | Especialización en Nefrología | spa |
| sb.sede | Sede Barranquilla | spa |
Archivos
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 2.93 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: